Showing results (21-30 of 35) with videos related to
Sort By:
Pageof 4
Nuclear Medicine and Molecular Imaging|January 30, 2025
Preparation and Biodistribution Assessment of <sup>177</sup>Lu-curcumin as a Possible Therapeutic AgentSara Vosoughi, Nafise Salek, Mohammad Ghannadi Maragheh, et al.IEEE Transactions on Nanobioscience|July 21, 2018
Highly Stable 177Lu-Organic Framework as a Potential Agent for Treatment of Metastatic BoneNafiseh Salek, Ali Bahrami-Samani, Simindokht Shirvani-Arani, et al.Scientia Pharmaceutica|December 24, 2010
Production, quality control and pharmacokinetic studies of Ho-EDTMP for therapeutic applicationsAli Bahrami-Samani, Reza Bagheri, Amir R Jalilian, et al.Iranian Journal of Basic Medical Sciences|July 5, 2013
Development of (177)Lu-phytate Complex for RadiosynovectomyHassan Yousefnia, Amir Reza Jalilian, Ali Bahrami-Samani, et al.Scientia Pharmaceutica|July 21, 2011
Preparation and quality control of the [sm]-samarium maltolate complex as a lanthanide mobilization product in ratsZohreh Naseri, Amir Hakimi, Amir R Jalilian, et al.Iranian Journal of Basic Medical Sciences|July 5, 2013
Production, Quality Control and Biological Evaluation of (166)Ho-PDTMP as a Possible Bone Palliation AgentSamaneh Zolghadri, Amir Reza Jalilian, Zohreh Naseri, et al.Cancer Biotherapy & Radiopharmaceuticals|April 13, 2019
<sup>177</sup>Lu/<sup>153</sup>Sm-Ethylenediamine Tetramethylene Phosphonic Acid Cocktail: A Novel Palliative Treatment for Patients with Bone MetastasesMehrosadat Alavi, Farnaz Khajeh-Rahimi, Hassan Yousefnia, et al.Journal of Labelled Compounds & Radiopharmaceuticals|November 29, 2013
Preclinical evaluation of holmium-166 labeled anti-VEGF-A(Bevacizumab)Alireza Khorami-Moghadam, Bahram Bolouri, Amir Reza Jalilian, et al.Asia Oceania Journal of Nuclear Medicine & Biology|July 14, 2016
Treatment efficacy of (153)Sm-EDTMP for painful bone metastasisNarjess Ayati, Kamran Aryana, Amir Jalilian, et al.Journal of Cancer Research and Therapeutics|June 18, 2013
Optimization of 90 Y-antiCD20 preparation for radioimmunotherapyNazila Gholipour, Ariandokht Vakili, Edalat Radfar, et al.Pageof 4